Promising antibiotic candidate identified.
Enserink
M
M
D000900:Anti-Bacterial Agents / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D002462:Cell Membrane / Q000187:drug effects; D002473:Cell Wall / Q000378:metabolism; D006094:Gram-Positive Bacteria / Q000187:drug effects* / Q000378:metabolism; D008563:Membrane Lipids / Q000378:metabolism; D009561:Nisin / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D010457:Peptidoglycan; D011104:Polyisoprenyl Phosphate Oligosaccharides / Q000378:metabolism; D014640:Vancomycin / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D008563:Membrane Lipids; D010457:Peptidoglycan; D011104:Polyisoprenyl Phosphate Oligosaccharides; D009561:Nisin; C062770:undecaprenyl diphosphate-(N-acetylglucosaminyl)(1-4)-N-acetylmuramoyl pentapeptide; D014640:Vancomycin